AltAssets private equity deal roundup – January 9, 2024

EQT has announced its EQT Healthcare Growth Strategy alongside its first investment Mabtech, which is being acquired from the IK Small Cap II Fund. Mabtech provides tests and kits for studying immune responses predominantly in vaccine, infectious diseases, and oncology research. EQT is banking on potential returns from long-term trends such as growing, aging, and …